CD8A and neoplasm: Notably, Xia et al.191 demonstrated that SUS directly activates splenic CD4+ and CD8+ T cells in 4T1 tumor-bearing mice, enhances tumor-infiltrating lymphocyte accumulation, and modulates cytokines and chemokines in the tumor microenvironment, thereby suppressing tumor growth.